NEWS
Chengdu Shengnuo Biopharm Co., Ltd. Cordially Invites You to the 93rd API China Exhibition – Join the Dialogue on Innovation and Development in the Peptide Field
Chengdu Shengnuo Biopharm sincerely invites you to attend the 93rd China International Pharmaceutical Raw Materials, Intermediates, Packaging, and Equipment Trade Fair (API China 2025). Join us from November 12–14, 2025, at Booth No. 5L25, Hall N5, Chongqing International Expo Center, as we explore cutting-edge technologies and collaboration opportunities in the peptide sector.
Dear Valued Clients and Partners,
Chengdu Shengnuo Biopharm Co., Ltd. extends a warm invitation to the 93rd API China 2025. We look forward to gathering with you at the Chongqing International Expo Center to discuss the latest advances and future trends in peptide-related technologies and partnerships.
Exhibition Details
- Date: November 12–14, 2025
- Venue: Chongqing International Expo Center, China
- Booth No.: 5L25, Hall N5
About Shengnuo Biopharm
Shengnuo Biopharm is a high-tech enterprise recognized under China's "Specialized, Refined, Unique, and Innovative" enterprise classification, and has been listed since 2021. Integrating R&D, production, and sales, our business covers peptide APIs, cosmetic active peptides, CDMO services, and peptide formulations. As a leading enterprise in the domestic peptide API sector, Shengnuo provides end-to-end solutions from drug discovery to commercial manufacturing, delivering high-quality peptide-based pharmaceutical solutions to global clients.
Technology & R&D Capabilities
With over 20 years of dedicated research in peptides, Shengnuo Biopharm has established:
- A 3,000 sqm Peptide API Process R&D Laboratory
- A 1,500 sqm Peptide API Pilot Plant
- A 3,000 sqm GMP-grade Peptide API and Topical Formulation R&D Facility
- A 5,200 sqm Formulation R&D and Analytical Testing Laboratory
Our professional R&D team of over 400 experts has undertaken more than ten national and provincial scientific projects, including the National "Major New Drug Discovery" Program. Our pipeline spans multiple therapeutic areas such as gastroenterology, immunology, oncology, hepatitis B, diabetes, and obstetrics. To date, we have obtained over 20 drug approvals, making significant contributions to peptide drug R&D and industrial development in China.
Exhibition Highlights
At our booth, Shengnuo will present:
- Latest research outcomes in peptide APIs and formulations
- Innovative applications of cosmetic active peptides
- Integrated CDMO service solutions
- Opportunities for peptide technology collaboration and industrial exchange
We look forward to engaging with you in person, sharing the latest technological breakthroughs and market insights, and exploring potential collaboration pathways.
Contact Us
- Website: www.snbiopharmacy.com
- Tel & Whatsapp: +8618116577817
- Email: sinobiopharm@gmail.com
We sincerely welcome you to Booth 5L25, Hall N5—let’s shape the future of peptides together!
Shengnuo Biopharm – Dedicated to Peptides, Driven by Innovation!
Chengdu Shengnuo Biopharm Co., Ltd.
November 11, 2025
Hot news
Shengnuo Bio has signed a strategic agreement with a Brazilian "Belt and Road" institution to cooperate on the supply of peptide APIs, technology exchange, and market channel development, with a focus on promoting GLP-1 class APIs such as Semaglutide and Tirzepatide in the Brazilian market. This collaboration marks the extension of the company's overseas presence into the core South American market and provides a practical pathway for China-Brazil biomedical cooperation under the "Belt and Road" framework.
2025-12-08
The 93rd API China kicked off successfully in Chongqing on November 12, with Shengnuo Biopharm (Booth N5 Hall 5L25) getting off to a strong start on the first day. The exhibition floor was buzzing with professional exchanges, as the company's demonstration of its integrated, end-to-end capabilities in peptide APIs and CDMO services attracted numerous industry professionals for in-depth discussions and garnered widespread recognition. The exhibition is still ongoing, and we sincerely invite colleagues from across the industry to visit our booth to continue the dialogue and explore collaborative opportunities.
2025-11-12
Chengdu Shengnuo Biopharm sincerely invites you to attend the 93rd China International Pharmaceutical Raw Materials, Intermediates, Packaging, and Equipment Trade Fair (API China 2025). Join us from November 12–14, 2025, at Booth No. 5L25, Hall N5, Chongqing International Expo Center, as we explore cutting-edge technologies and collaboration opportunities in the peptide sector.
2025-11-11
October 30, 2025 – Chengdu Shengnuo Biopharm Co., Ltd. held the project commencement ceremony in Dayi Economic Development Zone, marking the official start of construction for the Semaglutide, Tirzepatide, and other peptide Active Pharmaceutical Ingredient (API) industrialization base project.
2025-10-31